Clinical trial

Study of Immunotherapy in Autoantibody Positive Psychosis

NCT02449746

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-08-01

PhaseNA

Study timeline

Study start (actual)2015-08-01Date precision: month

Registry last updated2018-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Psychosisunresolved

Auto Immune Disordersunresolved

Interventions

Plasma ExchangeBIOLOGICAL

Intravenous immunoglobulinBIOLOGICAL

Sponsors & collaborators

University of Cambridgelead sponsor

University of Oxfordcollaborator

Stanley Medical Research Institutecollaborator

McPin Foundationcollaborator

Mapped research locations

BirminghamUnited Kingdom1 CambridgeUnited Kingdom1 NottinghamUnited Kingdom1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02449746 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.